Hokuyaku Takeyama Holdings, Inc operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hokuyaku Takeyama Holdings, Inc with three other
drug stores in Asia:
Hin Sang Group International Holding Co Ltd
of Hong Kong
sales of 227.46 million Hong Kong Dollars [US$29.32 million]
of which 81%
was Product Development Segment),
Hua Xia Healthcare Holdings Limited
of Hong Kong
(1.57 billion Hong Kong Dollars [US$202.97 million]
of which 84%
was Pharmaceutical Wholesale), and
Hai-O Enterprise Berhad
based in Malaysia
(297.63 million Malaysian Ringgits [US$70.98 million]
of which 67%
was Multi-Level Marketing).
During the year ended March of 2016, sales at
Hokuyaku Takeyama Holdings, Inc were ¥225.15 billion (US$2.18 billion).
increase of 6.1%
versus 2015, when the company's sales were ¥212.11 billion.
Sales of Dispensing Business saw an increase
that was more than double the company's growth rate: sales were up
25.8% in 2016, from
¥10.66 billion to ¥13.41 billion.
Hokuyaku Takeyama Holdings, Inc also saw significant increases in sales in
Nursing Care Business (up 15.2% to ¥2.42 billion)
Not all segments of Hokuyaku Takeyama Holdings, Inc experienced an increase in sales in 2016:
sales of Ict Bussiness fell 7.7% to ¥989.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).
Hokuyaku Takeyama Holdings, Inc also experienced decreases in sales in
Other (down 3.9% to ¥49.00 million)